Delivery Order SPE2DB25D3201-SPE2DB25FNSRM
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB69E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,294.00 Firm Fixed Price Delivery Order contract is for the supply of 4,567,978,192 units of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00...
This federal contract award, valued at $10,059.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,308.08 Firm Fixed Price Delivery Order contract is for the supply of 4567331014 - MYCOPHENOLATE 500 MG TABLET 500S, with a completion date of February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,200.99, is for the delivery of 4567764368 - MYCOPHENOLATE 500 MG TABLET 100S. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This appears to be a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,266.19, is for the delivery of MYCOPHENOLATE 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, SPE2DB25D3005|SPE2DB25FQEMQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,019.85 firm fixed-price delivery order is for the supply of 4,567,999 units of the medication Mycophenolate 250 mg capsules. The contract has an ultimate completion date of April 23, 2025 and was awarded on April 22, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYCOPHENOLATE 500 MG TABLET 500S. The contract, valued at $1,388.16, has a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, to provide 4,565,265,370 units of Mycophenolate 200 mg/ml suspension, a critical pharmaceutical product. The contract has a total ceiling value of $1,271.31 and an ultimate completion date of July 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen has been awarded numerous federal contracts by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 200 mg/ml suspension in 160 ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,102.18 and a period of performance through April 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...